According to MedPage Today (4/28, Monaco), many children experiencing symptoms associated with attention-deficit/hyperactivity disorder (AD/HD) “may not be getting the treatment they need,” investigators concluded. The study revealed that “of 1,206 children with parent-reported” AD/HD, “only 26.2% ever received any form of outpatient mental healthcare.” What’s more, “only 12.9% of kids were currently receiving” AD/HD “medications; 8% were receiving stimulants and 5.1% were receiving atomoxetine (Strattera), guanfacine, or clonidine.”
HCPlive (4/28, Walter) reported that “11,723 patients” were included in the study, the findings of which were published online April 28 in JAMA Network Open.
Related Links:
— MedPage Today (requires login and subscription)